Maiwald press releases
Another success for Maiwald and betapharm Arzneimittel GmbH
We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...
Continue reading
Maiwald wins important opposition case for its client Acetate International LLC at the European Patent Office
Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...
Continue reading
Law firm will in future operate as Maiwald GmbH
Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...
Continue reading
Maiwald offers part of its office space to Munich volunteer organisation as a coordination hub for Ukrainian refugees
The patent attorneys’ firm of Maiwald has put part of its Munich office space at the disposal of the organisation “Münchner Freiwillige – Wir helfen e.V.” to use as a contact point for refugees fleeing Ukraine. From rooms in Elisenhof, located very close to...
Continue reading
Video Conference Without Consent of the Parties – Amicus Curiae Brief Filed in Connection With Case G 1/21 Before the Enlarged Board of Appeal of the EPO
Maiwald, together with other leading patent law firms, considers video conferencing without the consent of the parties to be inadmissible and has filed an amicus curiae brief in connection with the proceedings G 1/21 before the Enlarged Board of Appeal of the Europea...
Continue reading
Maiwald establishes practice for patent litigation in the field of standard-essential HEVC patents and video codec technologies against non-practicing entities
Maiwald is setting up a patent litigation team with partner Dr Simon Lud and two associates. Maiwald is mandated by Unified Patents, LLC, located in the USA.
Continue reading
Assignment of Phoma macrostoma Patents to Evologic Technologies
Her Majesty the Queen in Right of Canada, as represented by the Canadian Minister of Agriculture and Agri-Food (“AAFC”) and Evologic Technologies GmbH have entered into an assignment and licence agreement regarding the Phoma macrostoma technology.
Continue reading
Maiwald wins important victory at the German Federal Supreme Court
The German Federal Supreme Court revokes a supplementary protection certificate of the US pharmaceutical company Gilead for the HIV drug Truvada® The generic product of Maiwal...
Continue reading
Maiwald wins for PepsiCo
European Patent Office dismisses Coca-Cola appeal Maiwald secures a patent for PepsiCo for sweetened, acidic beverages with no bitter aftertaste.
Continue reading
President of the European Patent Office and Patent Attorneys Sit down Together
Open letter leads to dialogue The European Patent Office has started a constructive dialogue with patent attorneys and attorneys-at-law on the initiative of a number of law firms who are working to ensure that in...
Continue reading
Joint Press Release of Munich Patent Law Firms Grünecker, Hoffmann Eitle, Maiwald and Vossius & Partners
Patent Protection at Risk Open Letter to the European Patent Office: Quality of patent examinations at risk ...
Continue reading
Maiwald accompanies the acquisition of Pharmazeutische Fabrik Evers GmbH & Co. KG
Marco Stief, Partner, and Sebastian Haase, Sen...
Continue reading
Maiwald achieves landmark decision on the admissibility of undisclosed disclaimers (G1/16)
On 18 December 2017, the Enlarged Board of Appeal of the European Patent Office (EBoA) handed down the decision in case G 01/16, answering legal questions on the admissibility of undisclosed disclaimers and the applicability of the so-called “gold standard disclosure test...
Continue reading
Maiwald and PATEV agree on cooperation
Maiwald Patentanwaltsgesellschaft and the IP service provider PATEV have agreed on a cooperation in the area of in-house patent work. PATEV's "Patent Assistant" product offers companies access to expert advice on all aspects of in-house patents. Especially SMEs often lack th...
Continue reading
Maiwald represents Royalty Pharma in CJEU referral concerning sitagliptin SPC
Extended Patent Protection for Pharmaceutical Companies Prospect of Legal Certainty for all EU Member States Maiwald obtains a referral to the European Court of Justice.
Continue reading
Maiwald joins new UPC lawyers alliance
In the context of the newly created Unified Patent Court (UPC), Maiwald is pushing ahead with its drive to establish the firm as part of an international network of legal specialists. In April 2017, Maiwald joined the IP Lawyers Network UPCLA (Unified Patent Court Lawyers an...
Continue reading
Maiwald Joins New UPC Lawyers Alliance
In the context of the newly created Unified Patent Court (UPC), Maiwald is pushing ahead with its drive to establish the firm as part of an international network of legal specialists. In April 2017, Maiwald joined the IP Lawyers Network UPCLA (Unified Patent Court Lawyers an...
Continue reading
